Table 1. Characteristics of the Studies Selected (N = 400).
Characteristics | n (%) |
Funding (n = 400) * | |
Industry | 247 (61.7) |
Non-industry | 106 (26.5) |
Blended | 47 (11.8) |
Study Phase (n = 400) * | |
Phase 2 | 209 (52.3) |
Phase 3 | 130 (32.5) |
Phase 4 | 61 (15.2) |
Gender (n = 400) * | |
Both | 356 (89.0) |
Female only | 31 (7.7) |
Male only | 13 (3.3) |
Age Group (n = 400) | |
Adult only | 332 (83.0) |
Child involved | 68 (17.0) |
Randomization (n = 399) ** | |
Randomized | 271 (67.9) |
Not randomized | 128 (32.1) |
Investigator (n = 400) | |
Non-academia | 238 (59.5) |
Academia | 162 (40.5) |
Number of Study Subjects (n = 389) ** | |
Median | 98 |
Mean (SD) | 249 (452) |
Range | 1–5993 |
Study length (days) (n = 400) | |
Median | 639 |
Mean (SD) | 874 (817) |
Range | 29–6908 |
*Phase 3 and 4 were aggregated as “phase 3/4”, non-industry funded and blended studies were aggregated as “non-industry or blended” and female only and male only were aggregated as “male or female only” in the analysis.
**Some data were missing in CTG registry and the total number did not sum up 400.